Results for

Process audit - Manufacturer Producer - China

2 Companies

13 Products

TIANJIN YR CHEMSPEC TECHNOLOGY CO.,LTD.

China

YR Chemspec® is a qualified manufacturer and supplier which audited and approved by SGS, the company is strictly following the Quality Management System ISO9001: 2015. YR Chemspec® is engaged in the production and distribution a broad range portfolio of specialty, raw materials, active ingredients for the global cosmetic industries. We are always dedicated in state-of-the-art technology innovations, manufacturing process, distributing, sourcing high quality raw materials and ingredients. YR Chemspec® is an Industry-University-Research oriented company, to prompt high-quality development through innovation and fostering new growth drivers. YR Chemspec® is raising its capacity for pursuing scientific and technological innovation via cooperating with the famous universities and institutes. Main of our industry-university-research collaborative projects including, Vitamin Derivatives, Fermented Actives, Plant extracts, PVP Polymers, Polyquaterniums and other active ingredients.

Website See all products
HYBIO PHARMACEUTICAL CO. LTD.

China

Founded in 1998, Hybio is a leading peptide pharmaceutical company and the first going public in China (2011, stock code 300199). We offer a full range of peptide products (API & FDF) and services (CRO & CDMO). Hybio Group currently owns 8 subsidiaries and branches, with its Wuhan subsidiary as an API production base, Pingshan branch as a FDF production base, Changee subsidiary as a medical device base, Dali Biotech subsidiary as hemp processing base etc... Hybio Headquarters in Shenzhen has passed local & national NMPA GMP inspection for over 90 times, overseas FDA, EU, ANVISA, KFDA (etc.) GMP inspections for 8 times and customer audits for over 50 times. It owns over 300 invention patents and 102 PCTs, with more than 100 patents authorized. Hybio Wuhan subsidiary is a specialized peptide API manufacturing base, which was put into production in 2019. The full capacity for peptide API can be up to 1000kg/year and the current capacity is around 300kg/year. Main APIs are Liraglutide, Semaglutide, Tirzepatide, Glatiramer, Ganirelix, Cetrorelix, Degarelix, Atosiban, Oxytocin, Carbetocin, Terlipressin, Desmopressin, Linaclotide, Plecanatide, Leuprorelin, Triptorelin, Teriparatide, Eptifibatide, Octreotide, Lanreotide, Somatostatin, etc.

See all products

Find quotes for

Filters

Results for

Process audit - Manufacturer Producer - China

Number of results

2 Companies